Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 257 results from 1 sources
http://web.expasy.org/cellosaurus/CVCL_4231

Cite this KCB Cat# KCB 89001, RRID:CVCL_4231
Organism: Rusa unicolor
Disease:
Category: Finite cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_BS95

Cite this KCB Cat# KCB 94026, RRID:CVCL_BS95
Organism: Ovis aries
Disease:
Category: Finite cell line
Comment: Breed/subspecies: Diqing.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0343

Cite this KCB Cat# KCB 200720YJ, RRID:CVCL_0343
Organism: Rattus norvegicus
Disease:
Category: Finite cell line
Comment: Characteristics: Capable of at least 10 PDL. Doubling time: ~50 hours (DSMZ). Breed/subspecies: Charles River Sprague Dawley (CD(SD)).

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_1626

Cite this KCB Cat# KCB 200779YJ, RRID:CVCL_1626
Organism: Homo sapiens
Disease: Renal cell carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0001

Cite this KCB Cat# KCB 200808YJ, RRID:CVCL_0001
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this KCB Cat# KCB 2014051YJ, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0004

Cite this KCB Cat# KCB 90029YJ, RRID:CVCL_0004
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'K-652' in Cosmic 1523829. Misspelling: 'K652' in Cosmic 1516632 and Cosmic 2024372.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0006

Cite this KCB Cat# KCB 200549YJ, RRID:CVCL_0006
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0137

Cite this KCB Cat# KCB 2010186YJ, RRID:CVCL_0137
Organism: Rattus norvegicus
Disease:
Category: Spontaneously immortalized cell line
Comment: Breed/subspecies: BDIX.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0007

Cite this KCB Cat# KCB 200676YJ, RRID:CVCL_0007
Organism: Homo sapiens
Disease: Adult acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA). Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ). Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Proteome analysis by 2D-DE/MS. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: ATCC; CRL-1593. Discontinued: RCB; RCB1978.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0008

Cite this KCB Cat# KCB 2012116YJ, RRID:CVCL_0008
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0013

Cite this KCB Cat# KCB 200940YJ, RRID:CVCL_0013
Organism: Homo sapiens
Disease: Adult T acute lymphoblastic leukemia
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Part of: NCI60 cancer cell line panel. Doubling time: 31.56 +- 1.488 hours (PubMed=24762992); 33 hours (PubMed=17117183); 29 hours (PubMed=20922763); 27.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Instable (MSI-high) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Cys (PubMed=17088437). Sequence variation: Homozygous for PTEN p.Lys267fs*9 (PubMed=17088437). Sequence variation: Heterozygous for STK11 p.Gln214Ter (PubMed=17088437). Sequence variation: Heterozygous for TP53 p.Arg306Ter (PubMed=17088437). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0019

Cite this KCB Cat# KCB 2006107YJ, RRID:CVCL_0019
Organism: Homo sapiens
Disease: Neuroblastoma
Category: Cancer cell line
Comment: Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 810. Doubling time: >55 hours (DSMZ). Sequence variation: ALK p.Phe1174Leu (PubMed=28350380). Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: GPI-anchored proteins analysis by proteomics. Omics: Mitochondrial proteome analysis by 2D-DE/MS. Omics: N-glycan profiling. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'SH-SY5'. Derived from metastatic site: Bone marrow.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0021

Cite this KCB Cat# KCB 200965YJ, RRID:CVCL_0021
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this KCB Cat# KCB 2011101YJ, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this KCB Cat# KCB 200434YJ, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this KCB Cat# KCB 200710YJ, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0125

Cite this KCB Cat# KCB 200967YJ, RRID:CVCL_0125
Organism: Mus musculus
Disease: Malignant neoplasms of the mouse mammary gland
Category: Cancer cell line
Comment: Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG). Omics: Transcriptome analysis. Breed/subspecies: BALB/cfC3H.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0027

Cite this KCB Cat# KCB 200507YJ, RRID:CVCL_0027
Organism: Homo sapiens
Disease: Hepatoblastoma
Category: Cancer cell line
Comment: Problematic cell line: Misidentified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: JFCR45 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: ~50-60 hours (DSMZ). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Secretome proteome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Discontinued: JCRB; NIHS0326. Discontinued: RCB; RCB0459.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0030

Cite this KCB Cat# KCB 90024YJ, RRID:CVCL_0030
Organism: Homo sapiens
Disease: Human papillomavirus-related endocervical adenocarcinoma
Category: Cancer cell line
Comment: Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Characteristics: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(qll;q11q13;q24) and der(22)t(8;22)(q24;q13). Doubling time: ~48 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep membrane proteome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep quantitative proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: Glycoproteome analysis by proteomics. Omics: Myristoylated proteins analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line. Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377). Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line. Miscellaneous: HeLa is the most frequent contributor to cell lines contamination. Discontinued: ATCC; CRL-7923.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X